title: BRAFi-associated panniculitis - an emerging side effect with a variable histological picture: report of two cases and review of the literature.
authors.affiliation: Pathology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal.
authors.forename: Joana
authors.initials: J
authors.lastname: Ferreira
authors.affiliation: Dermatology Department, Hospital de Santarém, Santarém, Portugal.
authors.forename: Helena
authors.initials: H
authors.lastname: Toda-Brito
authors.affiliation: Dermatology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal.
authors.forename: Maria C
authors.initials: MC
authors.lastname: Moura
authors.affiliation: Dermatology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal.
authors.forename: Maria Fernanda
authors.initials: MF
authors.lastname: Sachse
authors.affiliation: Pathology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal.
authors.forename: Joaninha
authors.initials: J
authors.lastname: Costa-Rosa
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology / Q000473:pathology*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007211:Indoles / Q000009:adverse effects*; D008545:Melanoma / Q000188:drug therapy; D010091:Oximes / Q000009:adverse effects*; D015434:Panniculitis / Q000139:chemically induced* / Q000473:pathology; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors; D012878:Skin Neoplasms / Q000188:drug therapy; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D007211:Indoles; D010091:Oximes; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; C561627:dabrafenib
keywords: BRAF; panniculitis; side effect